INNOVATION STAGE

IT21 – Innovations in Inflammation and IOP Control

Presented by: Bausch + Lomb
Thursday, June 3 | 10:00 AM – 11:00 AM
Speakers: Mile Brujic, OD, FAAO, Michael Chaglasian, OD, FAAO

This session will provide insights and updates on Bausch & Lomb’s portfolio of innovative anti-inflammatory and IOP-reducing pharmaceuticals.  The speakers will cover clinical trial data for each medication, share their real-world takeaways on clinical use, and cover important prescribing information for the treatment of patients in optometry practices.

IT23 – Innovation Through Experience

Presented by: Bausch + Lomb
Thursday, June 3 | 1:00pm – 2:00pm
Speakers: April Jasper OD, FAAO; Mile Brujic OD, FAAO

Industry thought leaders share key insights about and experiences with the latest innovations in multi-focal toric and daily disposable SiHy contact lenses from Bausch + Lomb.

IT24 – Establishing a Sports Vision Practice- Tips from the Pros

Presented by the International Sports Vision Association
Thursday, June 3  |  3:00 PM – 4:00 PM
Speaker: Dr. Charles Shidlofsky, OD, FCOVD

Join Dr. Shidlofsky as he discusses ways to establish a sports and performance vision training center and new technologies available.   Sports vision enhancement gives athletes of all sports and abilities an "edge" in their performance.  Athletes improve reaction time, awareness, anticipation, timing, decision making and overall performance. This one hour lecture will include testing and training protocols, technology and tools available, marketing, outreach and vision skills needed for specific sports.  Attendees will learn different ways to incorporate this niche into their practice, gain insight into different instruments available, and learn different ways that optometrists are offering their training to patients and athletes.

IT31 – Experience & Evidence: Insights on Chronic Dry Eye Management

Presented by: Allergan
Friday, June 4 | 10:00am – 11:00am
Speakers: Josh Johnston OD, FAAO

Dr. Josh Johnston, a key opinion leader in ocular disease, will lead a discussion featuring case studies and clinical data focused on chronic dry eye management.